EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Enhancing safety: Multi‐institutional FMEA and FTA on 177Lu$^{177}{\rm Lu}$‐based radio‐pharmaceutical therapy

Siju C George iD, Santiago Aguirre iD, Nichole M Maughan iD, Ranjini Tolakanahalli iD, E James Jebaseelan Samuel iD, Sven L Gallo iD, Jacqueline E Zoberi iD, Yongsook C Lee iD

Journal of Applied Clinical Medical Physics · 2025

DOI: 10.1002/acm2.14550 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Applied Clinical Medical Physics, 2025. Verfasst von Siju C George und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Miami Cancer Institute, Baptist Health, Miami, Florida, USA. Hauptthemen laut MEDLINE: Radiotherapy Dosage. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study investigates potential failure modes and conducts failure mode and effects analysis (FMEA) and fault tree analysis (FTA) on the administration of DOTATATE (LUTATHERA) and PSMA‐617 (PLUVICTO). The quality management (QM) process in radiopharmaceutical therapies (RPTs) requires collaboration between nuclear medicine (NM) and radiation oncology (RO) departments. As part of a multi‐institutional study, we surveyed various departments to identify and analyze failure modes, leading to a proposed comprehensive QM program. RPT teams in RO or NM clinics can benefit from this study by continually improving their practice.

Methods

We reviewed the literature to investigate the administration of Pluvicto and Lutathera, focusing on prospective procedural failures and potential failure modes (PFMs) and their outcomes. We distributed an FMEA survey to multiple experienced centers in ‐based RPTs and calculated risk priority number (RPN) for various PFM. We conducted an FTA using this information to pinpoint the root causes of potential failures.

Results

The findings from the literature review and survey responses on the prospective study have identified several critical areas at risk of failure. These areas include non‐optimized treatment delivery, inadequate patient monitoring, and lack of safety training, leading to radiation contamination from the dose excreted by the patients after treatment administration. A segmented FTA was created based on the FMEA results, focusing on radiation contamination with a high RPN value.

Conclusion

By identifying the root causes of failures and proposing targeted improvements to the existing QM measures, this analysis enhances safety in treatment delivery of ‐based RPTs. Given the limited number of prospective risk analysis studies in RPTs, our research addresses the necessity for more such studies and recommends methods to apply this study to other RPTs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy DosageHumansRadiopharmaceuticalsHealthcare Failure Mode and Effect AnalysisMaleRadiotherapy Planning, Computer-AssistedProstatic NeoplasmsQuality Assurance, Health CareRadioisotopesLutetium

Stichwörter der Autor:innen

177 Lu $^{177}{\rm Lu}$ radiopharmaceutical therapyfailure mode effects analysisfault tree analysisprocess mapprospective analysisquality management

Substanzen

RadiopharmaceuticalsRadioisotopesLutetium

Autor:innen und Institutionen

  • Department of Radiation Oncology, Miami Cancer Institute, Baptist Health, Miami, Florida, USA.
  • Department of Physics, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
  • Department of Radiation Oncology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.
  • Department of Radiation Oncology, Intermountain Health, Provo, Utah, USA.
  • Department of Nuclear Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.

ORCID-Profile: Siju C George, Santiago Aguirre, Nichole M Maughan, Ranjini Tolakanahalli, E James Jebaseelan Samuel, Sven L Gallo, Jacqueline E Zoberi, Yongsook C Lee

Zitieren

APA

George, S. C., Aguirre, S., Maughan, N. M., Tolakanahalli, R., Samuel, E. J. J., Gallo, S. L., Zoberi, J. E., & Lee, Y. C. (2025). Enhancing safety: Multi‐institutional FMEA and FTA on 177Lu$^{177}{\rm Lu}$‐based radio‐pharmaceutical therapy. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.14550

Vancouver

George SC, Aguirre S, Maughan NM, Tolakanahalli R, Samuel EJJ, Gallo SL, et al. Enhancing safety: Multi‐institutional FMEA and FTA on 177Lu$^{177}{\rm Lu}$‐based radio‐pharmaceutical therapy. Journal of Applied Clinical Medical Physics. 2025. doi:10.1002/acm2.14550

BibTeX
@article{George2025,
  author = {George, Siju C and Aguirre, Santiago and Maughan, Nichole M and Tolakanahalli, Ranjini and Samuel, E James Jebaseelan and Gallo, Sven L and Zoberi, Jacqueline E and Lee, Yongsook C},
  title = {Enhancing safety: Multi‐institutional FMEA and FTA on 177Lu$^177\rm Lu$‐based radio‐pharmaceutical therapy},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2025},
  doi = {10.1002/acm2.14550}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche